(MedPage Today) — This article includes a first-person perspective from early breast cancer patient Lina. Lina was compensated for her time by Novartis.
Some patients with hormone receptor (HR)-positive, human epidermal growth factor receptor…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
